Combining Novo Nordisk Korea’s Expertise in Obesity Treatment

Kakao Healthcare announced on February 3 that it has introduced an "Obesity Patient Support Service" in collaboration with the global pharmaceutical company Novo Nordisk Korea, aimed at patients prescribed obesity treatments. The service is available through Kakao Healthcare's AI-based mobile health management solution, the PASTA app.


Kakao Healthcare Introduces Obesity Patient Support Service to 'PASTA' App View original image

This collaboration was launched to combine Novo Nordisk's expertise in obesity treatment with Kakao Healthcare's digital healthcare technology, with the goal of creating an environment where patients with obesity can receive safe and systematic management.


The service implemented in the PASTA app provides essential medication information such as injection and storage methods for obesity treatments, as well as dosage escalation schedules. It also features medication reminders to help improve treatment adherence. In addition, users can intuitively track changes in weight and muscle mass, while AI technology comprehensively analyzes factors such as diet, exercise, sleep, and stress patterns to suggest personalized routines. Through this, patients with obesity can reduce potential risk factors throughout the entire course of treatment and continue therapy in a stable manner.


Healthcare professionals can use "PASTA Connect PRO" to monitor not only weight changes but also key life-log data recorded in PASTA, such as exercise and dietary habits, in real time. This enables them to provide effective consultations and care that comprehensively consider the patient's lifestyle and treatment response.


Meanwhile, the two companies have been collaborating in various fields, including blood glucose and obesity management, since signing a business agreement in 2023. They are also providing a medication management solution for diabetes patients by integrating Novo Nordisk's FlexTouch insulin pen smart cap, Mallya, with Kakao Healthcare's PASTA app.


Casper Roseu Poulsen, CEO of Novo Nordisk Korea, stated, "Obesity is a chronic disease that requires long-term follow-up and lifestyle modification, and the key to successful treatment lies in professional prescriptions by healthcare providers and active participation by patients. The obesity patient support service through the PASTA app will offer patients a more sophisticated and integrated treatment experience, and contribute to improving a sustainable management environment for those living with obesity."



Hwang Hee, CEO of Kakao Healthcare, commented, "The significance of this collaboration lies in creating an environment where patients can easily access clinically validated medication information and proactively manage their health based on data. By combining Novo Nordisk's global expertise in obesity treatment with Kakao Healthcare's digital technology, we will continue to expand a patient-centered digital healthcare ecosystem."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing